Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pociredir (FTX-6058) is a potent, selective, and orally active inhibitor of embryonic ectoderm development (EED) with a KD of 0.163 nM, possessing research value in inflammatory conditions or hemoglobinopathies such as sickle cell disease (SCD).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,140 | 10-14 weeks | |
50 mg | $2,785 | 10-14 weeks | |
100 mg | $3,520 | 10-14 weeks |
Description | Pociredir (FTX-6058) is a potent, selective, and orally active inhibitor of embryonic ectoderm development (EED) with a KD of 0.163 nM, possessing research value in inflammatory conditions or hemoglobinopathies such as sickle cell disease (SCD). |
In vivo | Pociredir (FTX-6058) (QD, 5 mg/kg) reduces the H3K27me3 levels in the Townes mouse model of sickle cell disease (SCD). Pociredir (FTX-6058) (QD, 5 mg/kg) increases the levels of red blood cells and total hemoglobin, ameliorates hemolysis in the Townes mouse model of sickle cell disease (SCD) [1]. |
Molecular Weight | 403.41 |
Formula | C22H18FN5O2 |
Cas No. | 2490674-02-5 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.